| Course | HLTH 5063 Biology and Disease Risk in Human Health |
|---|---|
| Module | Module 2 |
| Paper type | Noninfectious disease risk factor analysis |
| Length | 1,210 words, about 4 pages plus title and reference pages |
| Format | APA 7 student paper |
| School | American College of Education |
| Program | Master of Public Health |
| Updated | September 2026 |
Free sample paper for HLTH 5063 Module 2
One Cancer, Several Roads: Risk Factors for Liver Cancer in a County Where Hepatitis B, Alcohol and Metabolic Disease Overlap
Student Name
American College of Education
HLTH5063: Biology and Disease Risk in Human Health
Module 2 Assignment
Instructor Name
October 12, 2026
From Infection to Cancer
The previous module explained the biology of hepatitis B and showed that people infected as infants are very likely to develop lifelong chronic infection. This module follows that thread to its most serious consequence. Hepatocellular carcinoma, the most common form of primary liver cancer, is not itself infectious, but it arises most often in livers damaged by years of chronic inflammation. El-Serag (2012), reviewing its epidemiology, concluded that most cases are associated with cirrhosis related to chronic hepatitis B or hepatitis C infection, and that differences in liver cancer rates across regions, ages, sexes and racial groups largely reflect which hepatitis viruses are common in a population, when they spread and at what ages people were infected.
In the composite county, liver cancer incidence over the past five years was about 16 per 100,000 among Asian American residents, compared with about 7 per 100,000 among White residents, and it was rising among middle-aged men in several groups. This paper examines the risk factors that explain those patterns and how strongly each one raises risk.
Chronic Hepatitis B and the Role of Viral Load
Chronic hepatitis B is the leading cause of liver cancer worldwide, and its effect depends on how actively the virus is replicating. In a Taiwanese cohort of adults with chronic infection followed for an average of 11.4 years, Chen et al. (2006) found a clear dose-response relationship between the amount of virus in the blood at entry and later liver cancer. Incidence rose from 108 per 100,000 person-years among those with fewer than 300 copies per milliliter to 1,152 per 100,000 person-years among those with 1 million copies or more, corresponding to cumulative incidence of 1.3% and 14.9%. The gradient remained after adjustment for age, sex, smoking, alcohol, e antigen status, liver enzymes and cirrhosis.
The finding matters for prevention in two ways. It explains why liver cancer is concentrated among people infected early in life, who have lived with active infection for decades. And it shows that measuring viral load identifies who is at highest risk, which is why people found to have chronic infection need ongoing monitoring and, when indicated, antiviral treatment rather than a single diagnosis. For people living with hepatitis B, the amount of virus in the blood is not just a laboratory number; it is one of the best predictors of who will develop cancer.
Hepatitis C
Chronic hepatitis C is the other major viral cause, and in the United States it accounts for a large share of liver cancer among people born in the decades when injection drug use and unscreened blood transfusions spread the virus. Like hepatitis B, it causes cancer mainly through long-term inflammation and cirrhosis. Unlike hepatitis B, it can now be cured in most people with short courses of oral antiviral drugs, which lowers but does not eliminate liver cancer risk for those who already have advanced scarring. El-Serag (2012) noted that host, viral and environmental factors, including alcohol use and diabetes, modify the risk of liver cancer among people with either viral infection.
Alcohol
Heavy alcohol use damages the liver directly and is a major cause of cirrhosis in the United States. Its relationship with liver cancer is real but smaller than many assume at moderate levels. Turati et al. (2014), in a meta-analysis of 16 prospective studies with 19 cohorts, found no significant increase in liver cancer risk with moderate drinking of fewer than three drinks a day, a pooled relative risk of 0.91, but an increased risk with heavy drinking of three or more drinks a day, a relative risk of 1.16. The dose-risk curve suggested a roughly linear increase among drinkers, with an estimated 46% excess risk at 50 grams of ethanol a day and 66% at 100 grams. Alcohol also compounds viral hepatitis: a person with chronic hepatitis B or C who drinks heavily accumulates liver damage faster than one who does not.
Metabolic Liver Disease, Diabetes and Other Cofactors
A newer road to liver cancer runs through metabolic disease. Fatty liver associated with obesity, type 2 diabetes and related conditions, now called metabolic dysfunction-associated steatotic liver disease, can progress to inflammation, scarring and cirrhosis, and liver cancer can occasionally develop even without cirrhosis in this setting. Because obesity and diabetes are common and rising in the county, this pathway is likely to account for a growing share of cases, particularly among people without viral hepatitis. Diabetes also appears to increase risk among people who do have viral hepatitis, as El-Serag (2012) noted among the host factors that modify risk.
Other cofactors matter for particular groups. Tobacco smoking adds risk. Aflatoxin, a toxin produced by molds on improperly stored grains and nuts, is an important cofactor with hepatitis B in parts of Africa and Asia, which may contribute to lifetime risk among some immigrants who grew up where exposure was common, although it is rare in the United States food supply.
Protective Factors and Missed Chances
Risk factors tell only half the story; the other half is what lowers risk. Vaccination against hepatitis B in infancy has made new infections rare among young people in the United States, which will slowly shrink the pool of adults at risk of virus-related liver cancer. Treating chronic hepatitis C now cures most infections and reduces, though does not remove, later cancer risk. For people with chronic hepatitis B, antiviral drugs that suppress the virus lower the activity that drives liver damage, and regular ultrasound surveillance of those at highest risk can find tumors early, when surgery, ablation or transplant can still cure. Cutting heavy drinking and managing weight and blood sugar protect the liver regardless of viral status. In the county, many of these chances are being missed. Residents with chronic hepatitis B who have never been tested cannot be treated or monitored; residents with diabetes are rarely assessed for fatty liver disease; and liver cancer is often diagnosed only when symptoms appear, by which point cure is usually impossible. The most powerful protective factor is therefore simple: knowing one's status early enough to act on it.
Who Carries the Risk in the County
Putting the risk factors together explains the county's patterns. The higher incidence among Asian American residents reflects mainly chronic hepatitis B acquired early in life in countries of birth, sometimes compounded by cofactors. Rising incidence among middle-aged men across groups reflects a mix of hepatitis C in older birth cohorts, heavy alcohol use and a growing burden of obesity and diabetes. Many of those at highest risk do not know it: people with chronic hepatitis B often feel well and have never been tested, and people with metabolic liver disease rarely have symptoms until cirrhosis is advanced.
The analysis points to prevention at several levels. Finding and treating chronic viral hepatitis prevents the largest share of cases in high-burden communities. Monitoring people with chronic hepatitis B or cirrhosis for early liver cancer allows treatment when it can still succeed. Reducing heavy drinking and addressing obesity and diabetes will matter more over time. The next module examines why some people exposed to these risks develop disease and others do not.
References
Chen, C.-J., Yang, H.-I., Su, J., Jen, C.-L., You, S.-L., Lu, S.-N., Huang, G.-T., Iloeje, U. H., & REVEAL-HBV Study Group. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA, 295(1), 65-73. https://doi.org/10.1001/jama.295.1.65
El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142(6), 1264-1273. https://doi.org/10.1053/j.gastro.2011.12.061
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., Corrao, G., Boffetta, P., & La Vecchia, C. (2014). Alcohol and liver cancer: A systematic review and meta-analysis of prospective studies. Annals of Oncology, 25(8), 1526-1535. https://doi.org/10.1093/annonc/mdu020
HLTH 5063 Module 2 instructions, in plain terms
HLTH 5063 Module 2 commonly asks you to explain the risk factors for a chronic or noninfectious disease. Prompts usually ask you to identify the major risk factors, quantify how much each raises risk using studies, explain the biological mechanisms linking them to disease, and describe which populations carry them. Some versions ask you to distinguish modifiable from nonmodifiable factors or to rank them for prevention. Graders expect magnitudes, such as relative risks or incidence rates, from well-designed studies, not just lists. Choose a disease relevant to your community, and check the Canvas prompt for whether local data or a risk factor table is required.
How this HLTH 5063 Module 2 example is built
The worked analysis connects the previous module's infection to a noninfectious outcome and uses local incidence to frame the question. The leading risk factor is quantified with a cohort study showing a dose-response gradient, and its implications for monitoring are drawn out. Hepatitis C is presented as a distinct pathway with a different treatment outlook. Alcohol is quantified from a meta-analysis, including the absence of a clear effect at moderate levels. Metabolic liver disease and other cofactors are described with the populations for whom they matter. The final section integrates the factors to explain the county's patterns and organizes prevention by level.
Where the points sit in the HLTH 5063 Module 2 rubric
Risk factor rubrics usually reward accurate identification of major factors, quantification with credible studies, biological explanation and application to populations. Graders give more credit for effect sizes from cohort studies and meta-analyses than for statements that a factor increases risk, and they notice whether the studies chosen match the population being discussed. The biology criterion rewards explaining how each factor leads to disease. Application earns points when risk factors are linked to specific groups and patterns. Integration, showing how factors combine or interact, often distinguishes the best papers, especially when the paper explains which combination matters most in the community studied and what that means for where screening dollars go. Implications for prevention are commonly required. APA 7 citation of studies completes the rubric.
HLTH 5063 Module 2 help: mistakes that cost points
Risk factor papers lose marks when they list factors without saying how much each matters, or when they rely on news articles and websites for effect sizes. Another frequent problem is ignoring interaction, as when alcohol worsens viral hepatitis. Students also fail to connect risk factors to the populations that carry them. Report a relative risk or incidence for each major factor. Explain the mechanism briefly. Say who is most exposed. Note which factors can be changed, and by whom. Heart disease, lung cancer and type 2 diabetes fit this structure as well; share the disease and the grading guide, and the Module 2 risk factor paper can be written to your community's data.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official American College of Education document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More HLTH 5063 and Master of Public Health sample papers
- HLTH 5063 Module 1: Disease Biology and Transmission
- HLTH 5063 Module 3: Host Susceptibility Analysis
- HLTH 5063 Module 4: Biology and Policy Analysis
- HLTH 5063 Module 5: Policy Recommendation
- HLTH 5043 Module 2: Determinants of Health Analysis
- HLTH 5083 Module 3: Capstone Options Analysis
- HLTH 5043 Module 5: Program Evaluation Plan
- HLTH 5043 Module 1: Health Disparity Documentation
HLTH 5063 Module 2 questions, answered
What does HLTH5063 Module 2 usually ask for?
The second HLTH5063 module often asks you to analyze the risk factors for a noninfectious disease, explaining how strongly each raises risk, the biology behind it and which populations carry it. The disease is chosen in your own section.
What is the main cause of liver cancer?
Worldwide, most hepatocellular carcinoma is associated with cirrhosis from chronic hepatitis B or C infection, with alcohol and metabolic liver disease also important causes.
Does hepatitis B viral load affect liver cancer risk?
Yes. A large cohort study found liver cancer incidence rose steadily with the amount of virus in the blood, even after adjusting for other factors.
Where can I find a free HLTH 5063 Module 2 sample paper?
Right here: the complete Module 2 analysis of liver cancer risk factors, from hepatitis B viral load and hepatitis C to alcohol, metabolic liver disease and cofactors, applied to a county's patterns.
Does moderate drinking raise liver cancer risk?
A meta-analysis of prospective studies found no significant increase with moderate drinking but a higher risk with heavy drinking, rising roughly in line with the amount consumed.